Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573540
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not Yet RecruitingNot Applicable
NCT07573540Not Yet Recruiting
Not Applicable
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alc...
NCT07573787
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste DisordersChristoph GrimmTerminatedNot Applicable
NCT07573787Terminated
Not Applicable
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Dis...Christoph Grimm
NCT07572552
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisTanta UniversityNot Yet RecruitingPhase 2
NCT07572552Not Yet Recruiting
Phase 2
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymar...Tanta University
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07572851
Functional Changes and Fall Risk in Older Adults Participating in a Frailty ProgramUniversity of VigoEnrolling By Invitation
NCT07572851Enrolling By Invitation
—
Functional Changes and Fall Risk in Older Adults Participating in a Frailty Prog...University of Vigo
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07574151
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease SurveillanceUniversity of NottinghamRecruiting
NCT07574151Recruiting
—
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on...University of Nottingham
NCT07574385
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine IncRecruitingPhase 2
NCT07574385Recruiting
Phase 2
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine Inc
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07574021
The Experience of Short Video Addiction Among College StudentsSun Yat-sen UniversityNot Yet Recruiting
NCT07574021Not Yet Recruiting
—
The Experience of Short Video Addiction Among College StudentsSun Yat-sen University
NCT07572305
Effects of Virtual Reality After Liver TransplantationMalatya Turgut Ozal UniversityCompletedNot Applicable
NCT07572305Completed
Not Applicable
Effects of Virtual Reality After Liver TransplantationMalatya Turgut Ozal Unive...
NCT07574333
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including ElderlyNational Medical Research Center for Therapy and Preventive MedicineRecruitingNot Applicable
NCT07574333Recruiting
Not Applicable
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in...National Medical Research...
NCT07571954
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center Prospective StudyiVascular S.L.U.Not Yet RecruitingNot Applicable
NCT07571954Not Yet Recruiting
Not Applicable
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center...iVascular S.L.U.
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07574307
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07574307Recruiting
Not Applicable
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül Uni...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573306
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery PatientsUniversity of MinnesotaNot Yet Recruiting
NCT07573306Not Yet Recruiting
—
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Ca...University of Minnesota
NCT07572435
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Patients With Complex Congenital Heart DiseaseSeoul National University HospitalRecruitingNot Applicable
NCT07572435Recruiting
Not Applicable
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Pat...Seoul National University...
NCT07572591
Ultrasound for Peripheral Nerve ModulationStanford UniversityNot Yet RecruitingNot Applicable
NCT07572591Not Yet Recruiting
Not Applicable
Ultrasound for Peripheral Nerve ModulationStanford University
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Enrolling by invitation2 (10%)
Terminated1 (5%)
Completed1 (5%)
not_applicable9 (45%)
Phase 26 (30%)
Not Specified4 (20%)
Phase 11 (5%)